{"id":"W2105026490","doi":"10.1200/jco.2007.14.8924","title":"Role of <i>KRAS</i> and <i>EGFR</i> As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":665,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Erlotinib; KRAS; Medicine; Epidermal growth factor receptor; Hazard ratio; Fluorescence in situ hybridization; EGFR inhibitors; Internal medicine; Oncology; Erlotinib Hydrochloride; Cancer research; Cancer; Biology; Gene; Colorectal cancer; Genetics; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01226896,0.0001211286,0.002259805,0.0002082199,0.00002877827,0.000001469214,0.0001257618,0.0001934005,0.00005428785],"category_scores_gemma":[0.01918736,0.0000869868,0.000296888,0.0002891482,0.0003134618,0.00008328952,0.00004473938,0.0003668423,4.01375e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002974233,"about_ca_system_score_gemma":0.0167258,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03538412,"about_ca_topic_score_gemma":0.09725235,"domain_scores_codex":[0.9923346,0.001571964,0.005094852,0.000198457,0.0006419923,0.0001581274],"domain_scores_gemma":[0.9893016,0.006695404,0.002712283,0.0001378758,0.0008031431,0.0003496826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06258963,0.006076464,0.8902227,0.00003827105,0.002367932,0.0003429398,0.0008674911,0.00008974974,0.002401716,0.00006733015,0.009072067,0.02586373],"study_design_scores_gemma":[0.02368397,0.016457,0.9189883,0.0001676571,0.0006069365,0.00009771717,0.0007349998,0.000009943181,0.0001998259,0.0000938048,0.03888576,0.0000741145],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919086,0.000641709,0.000005597446,0.004614903,0.001031743,0.0006178043,0.00005343138,0.00000164819,0.001124564],"genre_scores_gemma":[0.9965467,0.0005884502,0.001072104,0.001316783,0.000301235,0.00001296301,0.000002297962,0.000009676074,0.000149788],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06186823,"threshold_uncertainty_score":0.9890745,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1692448192514435,"score_gpt":0.5560504929225468,"score_spread":0.3868056736711033,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}